Skip to main content
Caplight Logo









Copptech

Copptech

Private
LondonFrontier & Industrial Techhttps://www.copptech.com/

Last Round

Series B

Oct 5, 2022

Total Funding Raised

$8.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Copptech is a biotechnology company that develops and provides patented antimicrobial technology and ingredients used to eliminate viruses, bacteria, and fungi in various manufacturing processes.

Sector

Frontier & Industrial Tech

Verticals

Advanced Materials, Biotechnology, Clean Manufacturing

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial additivesantimicrobial masterbatchingredient brandantimicrobial coatingsbiotechnologymaterials scienceantimicrobial textilesbacterial protectionsurface protectionbiocidal additivesenvironmental protection agencyEPAbiocidal products regulationBPRantimicrobial tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Copptech Comparables

Compare Copptech with similar companies based on industry and business-model similarity.

Copptech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioCote Limited
88%
SANITIZED AG
83%
Sciessent
81%

Copptech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 5, 2022
Series ASep 1, 2018

Key People

Founding team and executive leadership

luis amestica

Deputy Chief Technology Officer

Executive Team

Copptech Investors

Notable investors and investment history

Copptech investors
InvestorRounds
Aurus CapitalSeries A
Foresight Group LLPSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 38% MoM.

  • Apr 16, 2026

    Monthly visitors grew 486% MoM, from 36 to 211.

Copptech Filings

Explore SEC and related filing metadata, where available.

Copptech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Copptech's valuation, stock price, and market status.

Is Copptech a public or private company?

Copptech is a private company.

What is the current stock price of Copptech?

Copptech is a private company with no public stock price. No recent secondary market data is available.

How much is Copptech worth (valuation)?

Valuation information for Copptech is not publicly available.

Can I buy Copptech stock?

Copptech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Copptech's last funding round?

Copptech's most recent funding round was Series B on October 5, 2022.

Who are the main investors in Copptech?

Key investors in Copptech include Aurus Capital, Foresight Group LLP.

Will Copptech IPO soon?

No public IPO plans have been announced for Copptech.

How can I track Copptech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Copptech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range14
Year Founded2014
Last FundingOct 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?